Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zagury

Showing results (281-290 of 433) with videos related to

Pageof 44
Sort By:
Journal of Virology|January 9, 1999
Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive tat and gp160 proteinsA Lachgar, N Sojic, S Arbault, et al.
Annals of the Rheumatic Diseases|November 29, 2007
Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalphaL Delavallée, H Le Buanec, N Bessis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor mediumJ C Mazière, J C Landureau, P Giral, et al.
AIDS (London, England)|March 28, 2003
T-cell receptor excision circles (TREC) and maintenance of long-term non-progression status in HIV-1 infectionMax W Richardson, Andrij E Sverstiuk, Edward J Gracely, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individualsA Achour, O Picard, D Zagury, et al.
Journal of Medicinal Chemistry|March 27, 2014
NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking databaseNathalie Lagarde, Nesrine Ben Nasr, Aurore Jérémie, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2006
TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammationHélène Le Buanec, Laure Delavallée, Natacha Bessis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 1999
A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoidH Le Buanec, A Lachgar, B Bizzini, et al.
AIDS Research and Human Retroviruses|February 1, 1988
HIV-1 expression by T8 lymphocytes after transfectionR Cheynier, M Soulha, F Laure, et al.
Science (New York, N.Y.)|October 26, 1984
HTLV-III in cells cultured from semen of two patients with AIDSD Zagury, J Bernard, J Leibowitch, et al.
Pageof 44

Showing results (281-290 of 433) with videos related to

Sort By:
Pageof 44
Journal of Virology|January 9, 1999
Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive tat and gp160 proteinsA Lachgar, N Sojic, S Arbault, et al.
Annals of the Rheumatic Diseases|November 29, 2007
Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalphaL Delavallée, H Le Buanec, N Bessis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor mediumJ C Mazière, J C Landureau, P Giral, et al.
AIDS (London, England)|March 28, 2003
T-cell receptor excision circles (TREC) and maintenance of long-term non-progression status in HIV-1 infectionMax W Richardson, Andrij E Sverstiuk, Edward J Gracely, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individualsA Achour, O Picard, D Zagury, et al.
Journal of Medicinal Chemistry|March 27, 2014
NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking databaseNathalie Lagarde, Nesrine Ben Nasr, Aurore Jérémie, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2006
TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammationHélène Le Buanec, Laure Delavallée, Natacha Bessis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 1999
A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoidH Le Buanec, A Lachgar, B Bizzini, et al.
AIDS Research and Human Retroviruses|February 1, 1988
HIV-1 expression by T8 lymphocytes after transfectionR Cheynier, M Soulha, F Laure, et al.
Science (New York, N.Y.)|October 26, 1984
HTLV-III in cells cultured from semen of two patients with AIDSD Zagury, J Bernard, J Leibowitch, et al.
Pageof 44